All news from Gastroenterology

Drug Improving Liver Cancer Therapy

Researchers from many international institutions have teamed up to design a more effective drug for liver cancer therapy. Their compound may help improve survival rates and reduce adverse effects. Hepatocellular carcinoma, or primary liver cancer, tend to grow and expand at a fast rate.

If it is not caught early, this means that people who have been diagnosed with it may not survive longer than 11 months. Recent studies show that in the United States, hepatocellular carcinoma is the ninth leading cause of cancer-related deaths. The study was published in the journal PNAS.

An Alternative Treatment For Liver Failure Patients

A study shows that patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants. Acute Liver Failure occurs when a healthy liver is so seriously damaged it can no longer regrow and recover, leaving patients in urgent need of a transplant.

The liver helps support almost every other organ, by removing toxins, as well as making and storing the proteins and energy sources the body requires. Often the damaged liver can regrow and recover on its own, but when it suffers massive injury, regeneration may fail and even 24 hours without a fully working liver can be life-threatening.

Fatty Liver Disease Pandemic, New Gold Standard Developed

New study calls for human-based tools to unravel the pathogenesis of non-alcoholic steatohepatitis (NASH). The contribution of in silico, in vitro and pathways-based systems biology approaches to unraveling the pathogenesis of this disease are described, and how this human-relevant research can be used for anti-NASH drug development.